Statins, Bcl-2, and apoptosis: Cell death or cell protection?

Molecular Neurobiology

Volumn 48, Issue 2, 2013, Pages 308-314

  Wood, W Gibson ^a   Igbavboa, Urule ^a   Muller, Walter E ^b   Eckert, Gunter P ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Apoptosis; Bcl 2; Cancer; Cholesterol; Isoprenoids; Neurodegeneration; Neuroprotection; Statins

Indexed keywords

ATORVASTATIN; DEXAMETHASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PROTEIN BAX; PROTEIN BCL 2; SIMVASTATIN;

ACUTE LEUKEMIA; ALZHEIMER DISEASE; APOPTOSIS; CANCER CELL CULTURE; CELL DEATH; CELL PROTECTION; CONFERENCE PAPER; DNA DEGRADATION; DRUG CONCENTRATION; DRUG MECHANISM; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; NEOPLASM; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; OSTEOSARCOMA CELL; PROTEIN PRENYLATION;

ANIMALS; APOPTOSIS; CYTOPROTECTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84885324882     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8496-5     Document Type: Conference Paper

References (69)

1. Taylor F, Ward K, Moore THM, Burke M, Smith GD, Casas JP, Ebrahim S (2012) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 1:2-8
2. Werner N, Nickenig G, Laufs U (2002) Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 97:105-116
3. Liao JK, Laufs U (2004) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89-118
4. Wong WWL, Dimitroulakos J, Minden MD, Penn LZ (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:508-519
5. Hindler K, Cleeland CS, Rivera E, Collard CD (2006) The role of statins in cancer therapy. Oncologist 11:306-315
6. Elewa HF, El-Remessy AB, Somanath PR, Fagan SC (2010) Pharmacotherapy 30:169-176
7. Eckert GP, Muller WE, Wood WG (2007) Cholesterol-lowering drugs and Alzheimer's disease. Future Lipidol 2:423-432
8. Wood WG, Eckert GP, Igbavboa U, Muller WE (2010) Statins and neuroprotection: a prescription to move the field forward. Ann NY Acad Sci 1197:1-8
9. Bansal N, Houle AG, Melnykovych G (1989) Comparison of dexamethasone and lovastatin (mevinolin) as growth inhibitors in cultures of T-cell derived human acute leukemia lines (CEM). Leuk Res 13:875-882
10. Pérez-Sala D, Mollinedo F (1994) Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun 199:1209-1215
11. Jones KD, Couldwell WT, Hinton DR, Su Y, He S, Anker L, Law RE (1994) Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 205:1681-1687
12. Chang MY, Jan MS, Won SJ, Liu HS (1998) Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. Biochem Biophys Res Commun 248:62-68
13. Cerezo-Guisado MI, Alvarez-Barrientos A, Argent R, Garcìa- Marín LJ, Bragado MJ, Lorenzo MJ (2007) c-Jun N-terminal protein kinase signaling pathway mediates lovastatin-induced rat brain neuroblast apoptosis. Biochim Biophys Acta 1771:164-176
14. Ogunwobi OO, Beales IL (2008) Statins inhibit proliferation and induce apoptosis in Barett's esophageal adenocarcinoma cells. Am J Gastroenterol 103:825-837
15. Chao DT, Korsmeyer SJ (1998) Bcl-2 family: regulators of cell death. Annu Rev Immunol 16:395-419
16. Akhtar RS, Ness JM, Roth KA (2004) Bcl-2 family regulation of neuronal development and neurodegeneration. Biochim Biophys Acta 1644:189-203
17. Breckenridge DG, Xue D (2004) Regulation of mitochondrial membrane permeabilization by Bcl-2 family proteins and caspases. Curr Opin Cell Biol 16:647-652
18. Walensky LD (2006) Bcl-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 13:1339-1350
19. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, Huang DCS (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315:856-859
20. Youle RJ (2007) Cellular demolition and the rules of engagement. Science 315:776-778
21. Buemi M, Allegra A, Senatore M, Marino D, Medici MA, Aloisi C, DiPasquale G, Corica F (1999) Pro-apoptotic effect of fluvastatin on human smooth muscle cells. Eur J Pharmacol 370:201-203
22. Link A, Selejan S, Hewera L, Walter F, Nickenig G, Böhm M (2011) Rosuvastatin induces apoptosis in CD4(+)CD28(null) T cells in patients with acute coronary syndromes. Clin Res Cardiol 100:147-158
23. Jánosi J, Sebestyén A, Bocsi J, Barna G, Nagy K, Vályi-Nagy I, Kopper L (2004) Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells. Anticancer Res 24:1817-1822
24. Garcia-Román N, Alvarez AM, Toro MJ, Lorenzo MJ (2001) Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition. Mol Cell Neurosci 17:329-341
25. Blanco-Colio LM, Justo P, Daehn I, Lorz C, Ortiz A, Egido J (2003) Bcl-xl overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells. Kidney Int 64:181-191
26. Ahn KS, Sethi G, Aggarwal BB (2007) Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1. J Immunol 178:2507-2516
27. Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS (2008) Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer 123:951-957
28. Goc A, Kochuparambil ST, Al-Husein B, Al-Azayzih A, Mohammad S, Somanath PR (2012) Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis. BMC Cancer 12:409
29. Kwak HB, Thalacker-Mercer A, Anderson EJ, Lin CT, Kane DA, Lee NS, Cortright RN, Bamman MM, Neufer PD (2012) Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes. Free Radic Biol Med 52:198-207
30. Blanco-Colio LM, Villa A, Ortego M, Hernández-Presa MA, Pascual A, Plaza JJ, Egido J (2002) 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis 161:17-26
31. van de Donk NW, Kamphuis MM, Lokhorst HM, Bloem AC (2002) The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells. Leukemia 16:1362-1371
32. Jiang Z, Zheng X, Lytle RA, Higashikubo R, Rich KM (2004) Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem 89:168-178
33. + T cells. Cell Immunol 235:136-144
34. Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ (2006) RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ 13:1845-1856
35. Demyanets S, Kaun C, Pfaffenberger S, Hohensinner PJ, Rega G, Pammer J, Maurer G, Huber K, Wojta J (2006) Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochem Pharmacol 71:1324-1330
36. Aberg M, Wickström M, Siegbahn A (2008) Simvastatin induces apoptosis in human breast cancer cells in a NKkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa. Thromb Res 122:191-202
37. Tu YS, Kang XL, Zhou JG, Lv XF, Tang YB, Guan YY (2013) Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells. Eur J Pharmacol 670:356-364
38. Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U (1999) Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol 292:1-9
39. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7:687-692
40. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, Schubert-Zsilavecz M, Karas M, Muller WE, Wood WG (2005) Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther 312:786-793
41. Franke C, Nöldner M, Abdel-Kader R, Johnson-Anuna LN, Wood WG, Muller WE, Eckert GP (2007) Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol Dis 25:438-445
42. Patassini S, Giampà C, Martorana A, Bernardi G, Fusco FR (2008) Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. Neurosci Res 448:166-169
43. Malik S, Sharma AK, Bharti S, Nepal S, Bhatia J, Nag TC, Narang R, Arya DS (2011) In vivo cardioprotection by pitavastatin from ischemic-reperfusion injury through suppression of IKK/NF-κB and upregulation of pAkt-e-NOS. J Cardiovasc Pharmacol 58:199-206
44. Rajtík T, Carnická S, Szobi A, Mesároš ová L, Mát'uš M, Svec P, Ravingerová T, Adameová A (2012) Pleiotropic effects of simvastatin are associated with mitigation of apoptotic component of cell death upon lethal myocardial reperfusion-induced injury. Physiol Res 61(S2):S33-S41
45. Qin W, Lu Y, Zhan C, Shen T, Dou L, Man Y, Wang S, Xiao C, Bian Y, Li J (2012) Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL. Cardiovasc Drugs Ther 26:23-30
46. Doyon M, Hale TM, Huot-Marchand JE, Wu R, de Champlain J, DeBlois D (2011) Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo? Vascul Pharmacol 54:5-12
47. Johnson-Anuna LN, Eckert GP, Franke C, Igbavboa U, Muller WE, Wood WG (2007) Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem 101:77-86
48. Xu SZ, Zhong W, Watson NM, Dickerson E, Wake JD, Lindow SW, Newton CJ, Atkin SL (2008) Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2. J Thromb Haemost 6:692-700
49. Dong Q, Yang Y, Song L, Qian H, Xu Z (2011) Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase. Int J Cardiol 153:311-316
50. Zhao XH, Xu ZR, Zhang Q, Yang YM (2012) Simvastatin protects human osteosarcoma cells from oxidative stress-induced apoptosis through mitochondrial-mediated signaling. Mol Med Report 5:483-488
51. Lemoine S, Allouche S, Coulbault L, Cornet V, Massetti M, Galera P, Géard J-L, Hanouz J-L (2012) Mechanisms involved in cardioprotective effects of pravastatin administered during reoxygenation in human myocardium in vitro. Anesthesiology 116:824-833
52. Spampanato C, De Maria S, Sarnataro M, Giordano E, Zanfardino M, Baiano S, Carteni M, Morelli F (2012) Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of Bcl-2 gene expression. Int J Oncol 40:935-941
53. Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35:251-257
54. Mcfarlane SI, Muniyappa R, Francisco R, Sowers JR (2002) Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab 87:1451-1458
55. Eckert GP, Wood WG, Muller WE (2005) Statins: drugs for Alzheimer's disease? J Neural Transm 112:1057-1071
56. Li L, Zhang W, Cheng S, Cao D (2012) Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease. Mol Neurobiol 46:64-77
57. Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, Merville M-P, Bours V (2003) NF-κB2/p100 induces Bcl-2 expression. Leukemia 17:1349-1356
58. Kawamura T, Ono K, Morimoto T, Akao M, Iwai-Kanai E, Wada H, Sowa N, Kita T, Hasegawa K (2004) Endothelin-1-dependent nuclear factor of activated T lymphocyte signaling associates with transcriptional coactivator p300 in the activation of the B cell leukemia-2 promoter in cardiac myocytes. Circ Res 94:1492-1499
59. Butterick TA, Igbavboa U, Eckert GP, Sun GY, Weisman GA, Muller WE, Wood WG (2010) Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol 41:384-391
60. Park WH, Lee YY, Kim ES, Seol JG, Jung CW, Lee CC, Kim BK (1999) Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis. Anticancer Res 19:3133-3140
61. Igarashi M, Yamaguchi H, Hirata A, Tsuchiya H, Ohnuma H, Tominaga M, Daimon M, Kato T (2002) Mechanisms of inhibitory effects of cerivastatin on rat vascular smooth muscle cell growth. J Cardiovasc Pharmacol 40:277-287
62. Mück AO, Seeger H, Wallwiener D (2004) Class-specific pro-apoptotic effects of statins on human vascular endothelial cells. Z Kardiol 93:398-402
63. Kubota T, Fujisaki K, Itoh Y, Yano T, Sendo T, Oishi R (2004) Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol 67:2175-2186
64. Mück AO, Seeger H, Wallwiener D (2004) Inhibitory effect of statins on the proliferation of human breast cancer cells. Int J Clin Pharmacol Ther 42:695-700
65. Konturek PC, Burnat G, Hahn EG (2007) Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. J Physiol Pharmacol 58:141-148
66. Kaneko R, Tsuji N, Asanuma K, Tanabe H, Kobayashi D, Watanabe N (2007) Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. J Biol Chem 282:19273-19281
67. Gauthaman K, Manasi N, Bongso A (2009) Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells. Br J Pharmacol 157:962-973
68. Lee SK, Kim YC, Song SB, Kim YS (2010) Stabilization and translocation of p53 to mitochondria is linked to Bax translocation to mitochondria in simvastatin-induced apoptosis. Biochem Biophys Res Commun 391:1592-1597
69. Zhang W, Wu J, Zhou L, Xie HY, Zheng SS (2010) Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol 48:1167-1174